OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

PHARMING GRP EO-,01/  NL0010391025  /

Frankfurt
5/17/2024  8:01:59 AM Chg. +0.0080 Volume Bid5:37:18 PM Ask5:37:18 PM High Low
0.8495EUR +0.95% 0
Turnover: 0.0000		 -Bid Size: - -Ask Size: - 0.8495 0.8495
GlobeNewswire 5/8 Pharming Group reports first quarter 2024 financial results and provides business update
GlobeNewswire 4/24 Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 20...
GlobeNewswire 4/8 Pharming announces completion of enrollment in pediatric clinical trial of leniolisib
GlobeNewswire 4/3 Pharming Group to participate in April investor conferences
GlobeNewswire 3/14 Pharming Group reports fourth quarter and full year 2023 financial results
GlobeNewswire 2/29 Pharming Group to report fourth quarter and full year 2023 financial results on March 14
GlobeNewswire 2/8 Pharming Group to participate in February investor conferences
GlobeNewswire 1/8 Pharming Group announces updated full year 2023 guidance and Joenja® U.S. launch update
GlobeNewswire 12/13/2023 Pharming Group announces development plans for leniolisib for additional primary immunodeficiencies ...
GlobeNewswire 11/21/2023 Pharming announces first patient dosed in pediatric clinical trial for children aged 1 to 6 years fo...
GlobeNewswire 11/1/2023 Pharming Group to participate in November investor conferences
GlobeNewswire 10/26/2023 Pharming Group reports third quarter 2023 financial results
GlobeNewswire 10/12/2023 Pharming Group to report third quarter 2023 financial results on October 26
GlobeNewswire 9/25/2023 Pharming Group reports on results of the 2023 Extraordinary General Meeting of Shareholders
GlobeNewswire 3/6/2014 Pharming Reports On Preliminary Financial Results 2013
GlobeNewswire 2/24/2014 PHARMING AND SALIX ANNOUNCE EXTENSION OF PDUFA ACTION DATE FOR RUCONEST®
GlobeNewswire 11/8/2013 PHARMING AND SANTARUS ANNOUNCE NEW DATA FROM OPEN-LABEL REPEAT TREATMENT STUDY WITH RUCONEST
GlobeNewswire 11/7/2013 Pharming Reports On Financial Results For The First Nine Months Of 2013
GlobeNewswire 10/9/2013 Pharming announces €12.0 million private equity placement with institutional investors
GlobeNewswire 8/29/2013 Pharming redeems final tranche of convertible bond for cash
GlobeNewswire 8/1/2013 Pharming reports on financial results first half year 2013
GlobeNewswire 6/25/2013 Pharming and Santarus announce poster presentation of pivotal clinical data for RUCONEST® (recombina...
GlobeNewswire 6/18/2013 Santarus and Pharming announce FDA acceptance for review of RUCONEST (recombinant human C1 esterase ...
GlobeNewswire 5/16/2013 Pharming reports on financial results first quarter 2013
GlobeNewswire 4/17/2013 Pharming and Santarus announce submission of RUCONEST Biologics License Application to FDA